The John Prentice and Kevin Lewis Study

An Outcome-Based Clinical Survey of 63 Individuals Who Supplemented With a Proprietary Micro-dilution Human Growth Hormone (HGH) Spray Formulation, and Who Self-Assessed 37 Areas of Health and Fitness for 1-3 Months

PLEASE NOTE: The study described below was conducted using the same delivery technology used to deliver the GHRPs (Growth Hormone Releasing Peptides) and other polypeptides in the RENUVA Infuser Oral Spray formulation, and is not provided or meant to imply or suggest that a person taking the RENUVA Infuser Oral Spray product will have the same or similar results.

S U M M A R Y

Recently, a subjective outcome-based clinical survey was conducted over a three-year period on 63 survey subjects. The Growth Factor/MMC ("MMC System") spray system tested was comparable to the MMC System found in the Renuva Infuser product. Subjects rated their health on a scale of one to seven for 37 mental and physical health criteria. Criteria included such anti-aging assessment points as energy level; skin tone; muscle strength; resistance to colds; sexual performance; memory and other quality of life issues. Qualifying subjects ranked their overall health at two or more junctures before supplementation, after one month into the supplementation program, and for subsequent months.

Test subjects supplemented their diet with a micro-dilution oral spray MMC System formula. 90% documented very positive results in an average of 18.3 different health areas after one to three months of use. Four subjects documented positive improvement in all 37-health areas. The highest rating of 7 ("has never been better") was assessed 6% of the time for all health criteria for all test subjects. The outcome-based survey shows that test subjects subjectively determined that the MMC System spray supplement was beneficial to their overall quality of life.